BCRX Return on Tangible Equity | BIOCRYST PHARMACEUTICALS, INC.

BIOCRYST PHARMACEUTICALS, INC. (BCRX) Return on Tangible Equity

2026-06-30: Return Tang Equity 84.68%.
2026-03-31: Return Tang Equity 82.69%.
2025-12-31: Return Tang Equity -221.45%.
2025-09-30: Return Tang Equity 2.26%.

Complete source-backed return tang equity history.

Available history: 2009-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	84.68%
2026-03-31	82.69%
2025-12-31	-221.45%
2025-09-30	2.26%
2025-06-30	8.47%
2025-03-31	11.83%
2024-12-31	18.68%
2024-09-30	26.42%
2024-06-30	30.68%
2024-03-31	43.81%
2023-12-31	49.73%
2023-09-30	57.51%
2023-06-30	62.44%
2023-03-31	68.92%
2022-12-31	83.88%
2022-09-30	79.68%
2022-06-30	98.31%
2022-03-31	118.12%
2021-12-31	172.04%
2021-09-30	154.22%
2021-06-30	201.83%
2021-03-31	279.38%
2020-12-31	949.09%
2020-09-30	-371.45%
2020-06-30	-152.17%
2020-03-31	-3164.53%
2019-12-31	-284.68%
2019-09-30	324.11%
2019-06-30	1367.48%
2019-03-31	-473.31%
2018-12-31	-205.65%
2018-09-30	-128.12%
2018-06-30	-170.84%
2018-03-31	-124.63%
2017-12-31	-78.53%
2017-09-30	-50.42%
2017-06-30	-195.78%
2017-03-31	-120.77%
2016-12-31	-3494.55%
2016-09-30	-1722.41%
2016-06-30	-536.86%
2016-03-31	-182.34%
2015-12-31	-90.14%
2015-09-30	-57.08%
2015-06-30	-40.30%
2015-03-31	-78.01%
2014-12-31	-59.75%
2014-09-30	-46.67%
2014-06-30	-42.42%
2014-03-31	624.48%
2013-12-31	2673.89%
2013-09-30	-1047.86%
2013-06-30	413.74%
2013-03-31	1321.65%
2012-12-31	8608.15%
2012-09-30	-421.30%
2012-06-30	-293.63%
2012-03-31	-215.87%
2011-12-31	-384.63%
2011-09-30	-207.20%
2011-06-30	-128.26%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-221.45%
2024-12-31	18.68%
2023-12-31	49.73%
2022-12-31	83.88%
2021-12-31	172.04%
2020-12-31	949.09%
2019-12-31	-284.68%
2018-12-31	-205.65%
2017-12-31	-78.53%
2016-12-31	-3494.55%
2015-12-31	-90.14%
2014-12-31	-59.75%
2013-12-31	2673.89%
2012-12-31	8608.15%
2011-12-31	-384.63%
2010-12-31	-51.68%
2009-12-31	-15.59%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
ADMA BIOLOGICS, INC. (ADMA)	United States	$2.131B	11.16
Kodiak Sciences Inc. (KOD)	United States	$2.090B	-10.12
RECURSION PHARMACEUTICALS, INC. (RXRX)	United States	$2.080B	-3.78
Vericel Corp (VCEL)	United States	$2.011B	93.97
Greenland Mines Ltd (GRML)	United States	$2.362B
Vir Biotechnology, Inc. (VIR)	United States	$1.814B	-6.85
Beam Therapeutics Inc. (BEAM)	United States	$2.549B	-41.51
NOVAVAX INC (NVAX)	United States	$1.748B	-6.26
Hemab Therapeutics Holdings, Inc. (COAG)	United States	$1.672B
Immunocore Holdings plc (IMCR)		$1.613B	-90.43